123 studies found for:    "Bacterial Infections" | Canada
Show Display Options
Rank Status Study
1 Completed What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center?
Conditions: Bacterial Infections;   Gram-Positive Bacterial Infections;   Staphylococcal Infections
Intervention:
2 Completed Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings
Conditions: Streptococcal Infection;   Gram-positive Bacterial Infection;   Bacterial Infection
Interventions: Biological: Group B streptococcus vaccine;   Biological: Placebo
3 Completed A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
Conditions: Skin and Subcutaneous Tissue Bacterial Infections;   Wound Infection;   Cutaneous Abscess;   Burn Infection;   Cellulitis
Intervention: Drug: AFN-12520000
4 Completed BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
Condition: Bacterial Infections
Interventions: Drug: Ciprofloxacin single dose;   Drug: Ciprofloxacin triple dose
5 Completed
Has Results
Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
Conditions: Bacterial Infections;   Diabetic Foot;   Osteomyelitis
Interventions: Drug: Tigecycline;   Drug: Ertapenem
6 Recruiting Study of Complication Rates Associated With PICC for Left vs Right
Condition: Bacterial Infections
Interventions: Procedure: Placement of PICC in right arm;   Procedure: PICC placement in Left arm
7 Completed TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
Condition: Skin and Subcutaneous Tissue Bacterial Infections
Interventions: Drug: TR-701 FA;   Drug: Linezolid
8 Unknown  Hospital Wide Roll-Out of Antimicrobial Stewardship
Condition: Bacterial Infections
Intervention: Other: Antibiotic stewardship audit-and-feedback to prescribers of patients receiving 3rd or 10th day of targeted broadspectrum antibiotics
9 Recruiting Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Conditions: Acute Leukemias of Ambiguous Lineage;   Bacterial Infection;   Diarrhea;   Fungal Infection;   Musculoskeletal Complications;   Neutropenia;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Secondary Acute Myeloid Leukemia;   Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Intervention: Drug: levofloxacin
10 Completed Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source
Conditions: Procalcitonin;   Fever Without Source;   Bacterial Infection;   Bacteremia
Intervention: Other: Procalcitonin dosage PCT-Q test (Brahms, Germany)
11 Completed Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo
Conditions: Impetigo;   Skin Infections, Bacterial
Intervention: Drug: SB-275833 ointment, 1%
12 Completed Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection
Condition: Clostridium Difficile Infection
Interventions: Biological: VP20621;   Other: Placebo
13 Terminated Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia (CABP)
Interventions: Drug: JNJ-32729463;   Drug: moxifloxacin;   Drug: JNJ-32729463 (Open-Label)
14 Completed
Has Results
An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia
Conditions: Pneumonia;   Bacterial Pneumonia;   Ventilator-Associated Pneumonia;   Infections, Nosocomial
Intervention: Drug: doripenem
15 Completed Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®
Conditions: Diphtheria;   Pertussis;   Polio;   Hepatitis B;   Tetanus
Intervention: Biological: Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC
16 Completed
Has Results
Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine
Conditions: Tetanus;   Diphtheria;   Pertussis
Intervention: Biological: Tetanus-diphtheria-acellular pertussis (Tdap) vaccine
17 Completed Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose
Conditions: Pertussis;   Tetanus;   Diphtheria
Intervention: Biological: Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®)
18 Completed Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years
Conditions: Meningococcal Disease;   Meningococcal Meningitis
Intervention: Biological: Serogroup B meningococcal vaccine
19 Completed Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants
Conditions: Hepatitis B;   Tetanus;   Poliomyelitis;   Diphtheria;   Haemophilus Influenzae Type b;   Acellular Pertussis
Intervention: Biological: Infanrix™ hexa
20 Completed Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants
Conditions: Haemophilus Influenzae Type b;   Poliomyelitis;   Hepatitis B;   Serogroup C Meningococcal Diseases;   Diphtheria;   Pertussis;   Pneumococcal Diseases;   Tetanus
Interventions: Biological: GSK2202083A vaccine;   Biological: Prevenar 13®;   Biological: Infanrix hexa™;   Biological: Menjugate®;   Biological: Rotarix™

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years